Here, we interrogated steps of the STAT6 signaling cascade in the context of the clinically-relevant D419 mutation to determine how mutated STAT6 function is altered to promote DLBCL cell survival. This evidence concerns the gene STAT6 and diffuse large B-cell lymphoma.